Cargando…

Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers

Although venous invasion (VI) is a poor prognostic factor for patients with pancreatobiliary tract cancers, its histopathologic characteristics have not been well described. We evaluated the patterns of VI and the added benefit provided by CD31, desmin, and dual CD31‒desmin immunolabeling for identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Junyoung, Wood, Laura D., Hruban, Ralph H., Hong, Seung-Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703967/
https://www.ncbi.nlm.nih.gov/pubmed/33253282
http://dx.doi.org/10.1371/journal.pone.0242571
_version_ 1783616728550342656
author Shin, Junyoung
Wood, Laura D.
Hruban, Ralph H.
Hong, Seung-Mo
author_facet Shin, Junyoung
Wood, Laura D.
Hruban, Ralph H.
Hong, Seung-Mo
author_sort Shin, Junyoung
collection PubMed
description Although venous invasion (VI) is a poor prognostic factor for patients with pancreatobiliary tract cancers, its histopathologic characteristics have not been well described. We evaluated the patterns of VI and the added benefit provided by CD31, desmin, and dual CD31‒desmin immunolabeling for identification of VI. We included 120 surgically resected pancreatobiliary tract cancer cases—59 cases as a test set with known VI and 61 cases as a validation set without information of VI. VI was classified into three patterns: intraepithelial neoplasia-like (IN-like), conventional, and destructive. Hematoxylin and eosin (H&E) staining and CD31, desmin, and dual CD31‒desmin immunolabeling were performed. Foci number and patterns of VI were compared with the test and validation sets. More foci of VI were detected by single CD31 (P = 0.022) than H&E staining in the test set. CD31 immunolabeling detected more foci of the conventional pattern of VI, and desmin immunolabeling detected more foci of the destructive pattern (all, P < 0.001). Dual CD31‒desmin immunolabeling identified more foci of VI (P = 0.012) and specifically detected more foci of IN-like (P = 0.045) and destructive patterns (P < 0.001) than H&E staining in the validation set. However, dual CD31‒desmin immunolabeling was not helpful for detecting the conventional pattern of VI in the validation set. Patients with VI detected by dual CD31‒desmin immunolabeling had shorter disease-free survival (P <0.001) than those without VI. VI detected by dual CD31‒desmin immunolabeling was a worse prognostic indicator (P = 0.009). More foci of VI could be detected with additional single CD31 or dual CD31‒desmin immunolabeling. The precise evaluation of VI with dual CD31‒desmin immunolabeling can provide additional prognostic information for patients with surgically resected pancreatobiliary tract cancers.
format Online
Article
Text
id pubmed-7703967
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-77039672020-12-03 Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers Shin, Junyoung Wood, Laura D. Hruban, Ralph H. Hong, Seung-Mo PLoS One Research Article Although venous invasion (VI) is a poor prognostic factor for patients with pancreatobiliary tract cancers, its histopathologic characteristics have not been well described. We evaluated the patterns of VI and the added benefit provided by CD31, desmin, and dual CD31‒desmin immunolabeling for identification of VI. We included 120 surgically resected pancreatobiliary tract cancer cases—59 cases as a test set with known VI and 61 cases as a validation set without information of VI. VI was classified into three patterns: intraepithelial neoplasia-like (IN-like), conventional, and destructive. Hematoxylin and eosin (H&E) staining and CD31, desmin, and dual CD31‒desmin immunolabeling were performed. Foci number and patterns of VI were compared with the test and validation sets. More foci of VI were detected by single CD31 (P = 0.022) than H&E staining in the test set. CD31 immunolabeling detected more foci of the conventional pattern of VI, and desmin immunolabeling detected more foci of the destructive pattern (all, P < 0.001). Dual CD31‒desmin immunolabeling identified more foci of VI (P = 0.012) and specifically detected more foci of IN-like (P = 0.045) and destructive patterns (P < 0.001) than H&E staining in the validation set. However, dual CD31‒desmin immunolabeling was not helpful for detecting the conventional pattern of VI in the validation set. Patients with VI detected by dual CD31‒desmin immunolabeling had shorter disease-free survival (P <0.001) than those without VI. VI detected by dual CD31‒desmin immunolabeling was a worse prognostic indicator (P = 0.009). More foci of VI could be detected with additional single CD31 or dual CD31‒desmin immunolabeling. The precise evaluation of VI with dual CD31‒desmin immunolabeling can provide additional prognostic information for patients with surgically resected pancreatobiliary tract cancers. Public Library of Science 2020-11-30 /pmc/articles/PMC7703967/ /pubmed/33253282 http://dx.doi.org/10.1371/journal.pone.0242571 Text en © 2020 Shin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Shin, Junyoung
Wood, Laura D.
Hruban, Ralph H.
Hong, Seung-Mo
Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
title Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
title_full Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
title_fullStr Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
title_full_unstemmed Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
title_short Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
title_sort desmin and cd31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703967/
https://www.ncbi.nlm.nih.gov/pubmed/33253282
http://dx.doi.org/10.1371/journal.pone.0242571
work_keys_str_mv AT shinjunyoung desminandcd31immunolabelingfordetectingvenousinvasionofthepancreatobiliarytractcancers
AT woodlaurad desminandcd31immunolabelingfordetectingvenousinvasionofthepancreatobiliarytractcancers
AT hrubanralphh desminandcd31immunolabelingfordetectingvenousinvasionofthepancreatobiliarytractcancers
AT hongseungmo desminandcd31immunolabelingfordetectingvenousinvasionofthepancreatobiliarytractcancers